Differences between revisions 3 and 4
Revision 3 as of 2006-02-16 00:10:47
Size: 679
Editor: cosiapat1
Comment:
Revision 4 as of 2006-02-16 06:16:42
Size: 588
Editor: cosiapat1
Comment:
Deletions are marked like this. Additions are marked like this.
Line 4: Line 4:
Beginning February 2006, the Cytoscape developers team conducted interviews with users to to get feedback on current features of Cytoscape and gain insights into how Cytoshape can evolve in the future to better meet user needs. This page contains a table of contents for interviewers' notes. Beginning February 2006, the Cytoscape developers team conducted interviews with users to to get feedback on current features of Cytoscape and gain insights into how Cytoshape can evolve in the future to better meet user needs.
Line 6: Line 6:
To add a page to this category, add a link to this page on the last line of the page. You can add multiple categories to a page. A discussion guide and some guidelines for interviewing can be found on the DiscussionGuide page.
Line 8: Line 8:
'''List of interviews:''' '''Notes from Interviews:'''

Beginning February 2006, the Cytoscape developers team conducted interviews with users to to get feedback on current features of Cytoscape and gain insights into how Cytoshape can evolve in the future to better meet user needs.

A discussion guide and some guidelines for interviewing can be found on the DiscussionGuide page.

Notes from Interviews:

NazilaMiller: Interview with Nazila Miller, University of Kansas, Dept. of Pharmaceutical Chemistry

AmyWiles: Interview with Amy Wiles, University of Texas Health Sciences Center


UserInterviews (last edited 2009-02-12 01:03:01 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux